Leaders in Life Science Recruitment

News

The latest news on Talentmark's commercial and philanthropic activities

Event: Investment and Exit strategies for Life Sciences SMEs

Event: Investment and Exit strategies for Life Sciences SMEs

An evening of networking and industry debate at the National Liberal Club.

Talentmark presents the Scrip Award for the Management team of the year

Talentmark presents the Scrip Award for the Management team of the year

Talentmark presents the Scrip Award for the Management team of the year

Dafydd Wright Joins Talentmark

Dafydd Wright Joins Talentmark

Talentmark recruits Dafydd Wright, 2010 Recruiter of the Year

Celebrating 40 Years with Industry Debate

Celebrating 40 Years with Industry Debate

Talentmark celebrated its 40th anniversary with lively industry debate on 'Futureceuticals' at the Royal College of Surgeons

Talentmark's 2011 Charity Hike

Talentmark's 2011 Charity Hike

Shooting Star Children's Hospice and Chase Hospice Care for Children is this year's charity as Talentmark scales the French alps

Amber Burns Joins Talentmark

Amber Burns Joins Talentmark

New Executive Search Consultant

Mark Johnson Joins Talentmark

Mark Johnson Joins Talentmark

New Managing Consultant, Quality & Regulatory Science

Ben Pepper Promoted to Principal Researcher

Ben Pepper Promoted to Principal Researcher

Talentmark recruitment specialist is promoted to Senior Researcher

Talentmark Team Completes the Three Peaks Challenge

Talentmark Team Completes the Three Peaks Challenge

£1625 raised by Talentmark in challenging mountain hike

Talentmark Sponsors Pharmaceutical Society Dinner

Talentmark Sponsors Pharmaceutical Society Dinner

Popular industry event is sponsored by Talentmark

Current Opportunities


Browse

Industry News

FDA panel backs Vivus obesity drug Qnexa
FDA panel backs Vivus obesity drug Qnexa...

FDA moves to ease cancer drug shortages
FDA moves to ease cancer drug shortages...

Alex Gorsky to succeed William Weldon as J&J CEO
Alex Gorsky to succeed William Weldon as J&J CEO...

GSK takes up option to develop two Galapagos compounds
GSK takes up option to develop two Galapagos compounds...

Novartis bags rights to Enanta HCV drug in $440 million deal
Novartis bags rights to Enanta HCV drug in $440 million deal...